We would like to inform that the Company has received Trading Approval dated January 30, 2026, from BSE Limited for 3,15,50,000 equity shares of Rs. 5/- each allotted to promoter and non-promoters ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Telogica Ltd has received trading approval from BSE for 3,15,50,000 equity shares of Rs. 5 face value each, issued at a Rs. 3 premium (Rs. 8 per share) to promoters and non-promoters. These shares were allotted on a preferential basis upon conversion of 3,15,50,000 warrants. The shares will be tradable on BSE effective February 1, 2026. The company has also attached BSE's confirmation letter dated January 30, 2026.
This increases the total share count of Telogica, leading to dilution for existing shareholders. The fresh supply of shares entering the market from February 1, 2026 could create short-term selling pressure, though the warrants were likely issued earlier, so this is the conversion becoming effective rather than entirely new dilution news.